449 related articles for article (PubMed ID: 21242186)
1. MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia.
Schotte D; De Menezes RX; Akbari Moqadam F; Khankahdani LM; Lange-Turenhout E; Chen C; Pieters R; Den Boer ML
Haematologica; 2011 May; 96(5):703-11. PubMed ID: 21242186
[TBL] [Abstract][Full Text] [Related]
2. Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia.
Schotte D; Lange-Turenhout EA; Stumpel DJ; Stam RW; Buijs-Gladdines JG; Meijerink JP; Pieters R; Den Boer ML
Haematologica; 2010 Oct; 95(10):1675-82. PubMed ID: 20494936
[TBL] [Abstract][Full Text] [Related]
3. TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia.
Ramakers-van Woerden NL; Pieters R; Loonen AH; Hubeek I; van Drunen E; Beverloo HB; Slater RM; Harbott J; Seyfarth J; van Wering ER; Hählen K; Schmiegelow K; Janka-Schaub GE; Veerman AJ
Blood; 2000 Aug; 96(3):1094-9. PubMed ID: 10910927
[TBL] [Abstract][Full Text] [Related]
4. MiR-125b, miR-100 and miR-99a co-regulate vincristine resistance in childhood acute lymphoblastic leukemia.
Akbari Moqadam F; Lange-Turenhout EA; Ariës IM; Pieters R; den Boer ML
Leuk Res; 2013 Oct; 37(10):1315-21. PubMed ID: 23915977
[TBL] [Abstract][Full Text] [Related]
5. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R
Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750
[TBL] [Abstract][Full Text] [Related]
6. Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia.
Schotte D; Chau JC; Sylvester G; Liu G; Chen C; van der Velden VH; Broekhuis MJ; Peters TC; Pieters R; den Boer ML
Leukemia; 2009 Feb; 23(2):313-22. PubMed ID: 18923441
[TBL] [Abstract][Full Text] [Related]
7. Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment.
Holleman A; Cheok MH; den Boer ML; Yang W; Veerman AJ; Kazemier KM; Pei D; Cheng C; Pui CH; Relling MV; Janka-Schaub GE; Pieters R; Evans WE
N Engl J Med; 2004 Aug; 351(6):533-42. PubMed ID: 15295046
[TBL] [Abstract][Full Text] [Related]
8. Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia.
Stams WA; den Boer ML; Holleman A; Appel IM; Beverloo HB; van Wering ER; Janka-Schaub GE; Evans WE; Pieters R
Blood; 2005 Jun; 105(11):4223-5. PubMed ID: 15718422
[TBL] [Abstract][Full Text] [Related]
9. Acute leukemia: subtype discovery and prediction of outcome by gene expression profiling.
Downing JR
Verh Dtsch Ges Pathol; 2003; 87():66-71. PubMed ID: 16888896
[TBL] [Abstract][Full Text] [Related]
10. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling.
Yeoh EJ; Ross ME; Shurtleff SA; Williams WK; Patel D; Mahfouz R; Behm FG; Raimondi SC; Relling MV; Patel A; Cheng C; Campana D; Wilkins D; Zhou X; Li J; Liu H; Pui CH; Evans WE; Naeve C; Wong L; Downing JR
Cancer Cell; 2002 Mar; 1(2):133-43. PubMed ID: 12086872
[TBL] [Abstract][Full Text] [Related]
11. Pediatric acute lymphoblastic leukemia.
Carroll WL; Bhojwani D; Min DJ; Raetz E; Relling M; Davies S; Downing JR; Willman CL; Reed JC
Hematology Am Soc Hematol Educ Program; 2003; ():102-31. PubMed ID: 14633779
[TBL] [Abstract][Full Text] [Related]
12. Effect of microRNA-210 on prognosis and response to chemotherapeutic drugs in pediatric acute lymphoblastic leukemia.
Mei Y; Gao C; Wang K; Cui L; Li W; Zhao X; Liu F; Wu M; Deng G; Ding W; Jia H; Li Z
Cancer Sci; 2014 Apr; 105(4):463-72. PubMed ID: 24720529
[TBL] [Abstract][Full Text] [Related]
13. Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia.
Lugthart S; Cheok MH; den Boer ML; Yang W; Holleman A; Cheng C; Pui CH; Relling MV; Janka-Schaub GE; Pieters R; Evans WE
Cancer Cell; 2005 Apr; 7(4):375-86. PubMed ID: 15837626
[TBL] [Abstract][Full Text] [Related]
14. Integrative computational in-depth analysis of dysregulated miRNA-mRNA interactions in drug-resistant pediatric acute lymphoblastic leukemia cells: an attempt to obtain new potential gene-miRNA pathways involved in response to treatment.
Mesrian Tanha H; Mojtabavi Naeini M; Rahgozar S; Moafi A; Honardoost MA
Tumour Biol; 2016 Jun; 37(6):7861-72. PubMed ID: 26700663
[TBL] [Abstract][Full Text] [Related]
15. In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia.
Styczynski J; Pieters R; Huismans DR; Schuurhuis GJ; Wysocki M; Veerman AJ
Br J Haematol; 2000 Sep; 110(4):813-8. PubMed ID: 11054062
[TBL] [Abstract][Full Text] [Related]
16. The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia.
Holleman A; den Boer ML; de Menezes RX; Cheok MH; Cheng C; Kazemier KM; Janka-Schaub GE; Göbel U; Graubner UB; Evans WE; Pieters R
Blood; 2006 Jan; 107(2):769-76. PubMed ID: 16189266
[TBL] [Abstract][Full Text] [Related]
17. Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia.
Stam RW; Den Boer ML; Schneider P; de Boer J; Hagelstein J; Valsecchi MG; de Lorenzo P; Sallan SE; Brady HJ; Armstrong SA; Pieters R
Blood; 2010 Feb; 115(5):1018-25. PubMed ID: 19965632
[TBL] [Abstract][Full Text] [Related]
18. In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: a report of the Dutch and German Leukemia Study Groups.
Ramakers-van Woerden NL; Pieters R; Hoelzer D; Slater RM; den Boer ML; Loonen AH; Harbott J; Janka-Schaub GE; Ludwig WD; Ossenkoppele GJ; van Wering ER; Veerman AJ;
Med Pediatr Oncol; 2002 Jun; 38(6):379-86. PubMed ID: 11984797
[TBL] [Abstract][Full Text] [Related]
19. TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia.
Cayuela JM; Baruchel A; Orange C; Madani A; Auclerc MF; Daniel MT; Schaison G; Sigaux F
Blood; 1996 Jul; 88(1):302-8. PubMed ID: 8704188
[TBL] [Abstract][Full Text] [Related]
20. [microRNA expression in childhood acute granulocytic leukemia and its subtypes].
Luo XQ; Xu L; Ke ZY; Huang LB; Zhang XL; Zhang LD
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):831-5. PubMed ID: 22335948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
